Spain's Almirall Pledges $400M For Skin Drug Co. Aqua
Spanish drugmaker Almirall SA said Tuesday it would pay roughly $400 million for private equity-backed prescription skin-care company Aqua Pharmaceuticals LLC, a move that will diversify its holdings and allow it...To view the full article, register now.
Already a subscriber? Click here to view full article